Overview of the 2022 WHO classification of thyroid neoplasms

ZW Baloch, SL Asa, JA Barletta, RA Ghossein… - Endocrine …, 2022 - Springer
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …

Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease

I Califano, A Smulever, F Jerkovich, F Pitoia - Reviews in Endocrine and …, 2024 - Springer
Anaplastic thyroid cancer (ATC) is an infrequent thyroid tumor that usually occurs in elderly
patients. There is often a history of previous differentiated thyroid cancer suggesting a …

Thyroid carcinoma: phenotypic features, underlying biology and potential relevance for targeting therapy

J Hu, IJ Yuan, S Mirshahidi, A Simental, SC Lee… - International journal of …, 2021 - mdpi.com
Thyroid carcinoma consists a group of phenotypically heterogeneous cancers. Recent
advances in biological technologies have been advancing the delineation of genetic …

High grade differentiated follicular cell-derived thyroid carcinoma versus poorly differentiated thyroid carcinoma: a clinicopathologic analysis of 41 cases

LDR Thompson - Endocrine Pathology, 2023 - Springer
Criteria overlap for separating between malignant follicular epithelial cell-derived thyroid
gland neoplasms with high grade features of increased mitoses and tumor necrosis but …

Papillary thyroid carcinoma: current position in epidemiology, genomics, and classification

AK Lam - Papillary Thyroid Carcinoma: Methods and Protocols, 2022 - Springer
Papillary thyroid carcinoma is the most common type of thyroid malignancy both in adults
and pediatric population. Since the 1980s, there are changes in criteria in labelling thyroid …

Clinical use of molecular data in thyroid nodules and cancer

AS Alzahrani - The Journal of Clinical Endocrinology & …, 2023 - academic.oup.com
Over the past 3 decades, advances in the molecular genetics of thyroid cancer (TC) have
been translated into diagnostic tests, prognostic markers, and therapeutic agents. The main …

Opportunities and challenges of liquid biopsy in thyroid cancer

C Romano, F Martorana, MS Pennisi, S Stella… - International journal of …, 2021 - mdpi.com
Thyroid cancer is the most common malignancy of the endocrine system, encompassing
different entities with distinct histological features and clinical behavior. The diagnostic …

Clinical application of next-generation sequencing in advanced thyroid cancers

LX Ma, O Espin-Garcia, PL Bedard, T Stockley… - Thyroid, 2022 - liebertpub.com
Background: With the emergence of mutation-based systemic therapies for patients with
advanced thyroid cancer, molecular profiling has become an important component of care …

Poorly differentiated thyroid carcinoma: a clinician's perspective

J Tong, M Ruan, Y Jin, H Fu, L Cheng… - European Thyroid …, 2022 - etj.bioscientifica.com
Poorly differentiated thyroid carcinoma (PDTC) is a rare thyroid carcinoma originating from
follicular epithelial cells. No explicit consensus can be achieved to date due to sparse …

DIAGNOSIS OF ENDOCRINE DISEASE: Usefulness of genetic testing of fine-needle aspirations for diagnosis of thyroid cancer

P Stewardson, M Eszlinger… - European Journal of …, 2022 - academic.oup.com
Objective Genetic testing is increasingly used to diagnose or rule out thyroid cancer in
indeterminate fine-needle aspirations. This review evaluates the usefulness of these …